SOFIE
Culver City
About SOFIE
SOFIE brings that vision to life by increasing the adoption and application diversity of theranostics by removing the cost and complexity traditionally associated with the technology. With a full line of imaging and radiochemistry systems and a premier radiopharmacy network and contract manufacturing organization to supply novel agents for diagnosis and therapy, the company is dedicated to improving patient health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $44.6M
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2024)
- Website: sofie.com
- Phone: +113102153159
Industries & Categories
Biotechnology, Life Science, Manufacturing, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sofie-14406 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.